Valuation: InterCure Ltd.

Market Cap 161M 0 141M 131M 121M 226M 15.49B 230M 1.56B 609M 7.61B 604M 591M 26.33B P/E 2024
-4.01x
P/E 2025 -4.87x
Enterprise Value 297M 0 261M 243M 223M 418M 28.62B 425M 2.88B 1.13B 14.07B 1.12B 1.09B 48.64B EV / Sales 2024
1.69x
EV / Sales 2025 1.16x
Free-Float
60.83%
Yield 2024 *
-
Yield 2025 -
1 day+1.94%
1 week+3.23%
Current month-10.66%
1 month-3.26%
3 months+14.21%
6 months-1.47%
Current year-9.12%
1 week 279.9
Extreme 279.9
304.8
1 month 279.9
Extreme 279.9
345
Current year 225.3
Extreme 225.3
359
1 year 225.3
Extreme 225.3
605
3 years 225.3
Extreme 225.3
1,346
5 years 225.3
Extreme 225.3
2,635
10 years 146.83
Extreme 146.8255
6,317.95
Manager TitleAgeSince
Chief Executive Officer 55 24/12/2019
Director of Finance/CFO 47 01/03/2020
General Counsel - 01/04/2022
Director TitleAgeSince
Director/Board Member 50 03/09/2015
Director/Board Member 66 14/12/2014
Chairman 55 13/02/2025
Date Insider Type Main position Quantity % Market Cap.
18/03/26 Other

Chief Financial Officer

539,947 0.9874%
18/03/26 Other

Director

19,046 0.0348%
18/03/26 Other

Director

26,149 0.0478%
Change 5-day change 1-year change 3-year change Capi.($)
+1.94%+3.23%-42.83%-49.79% 52.8M
-1.03%-2.03%+26.97%+217.43% 221M
+2.15%-1.04%+6.74%+111.11% 133M
+3.12%+5.60%-36.23%-27.47% 132M
-0.25%-7.81%-21.96%-4.74% 79.9M
-6.02%-7.14%-9.30%-35.00% 79.16M
Average -0.01%-1.53%-12.77%+35.26% 116.28M
Weighted average by Cap. +0.11%-1.24%-3.85%+76.49%

Financials

2024 2025
Net sales 239M 0 210M 195M 179M 336M 23B 342M 2.32B 905M 11.31B 897M 877M 39.1B 270M 0 237M 221M 203M 381M 26.02B 386M 2.62B 1.02B 12.79B 1.01B 992M 44.23B
Net income -67.8M -0 -59.54M -55.37M -50.81M -95.48M -6.53B -96.95M -658M -257M -3.21B -255M -249M -11.1B -35.71M -0 -31.36M -29.17M -26.77M -50.29M -3.44B -51.07M -346M -135M -1.69B -134M -131M -5.85B
Net Debt 133M 0 117M 108M 99.5M 187M 12.78B 190M 1.29B 503M 6.29B 498M 488M 21.73B 136M 0 120M 111M 102M 192M 13.13B 195M 1.32B 517M 6.45B 512M 501M 22.32B
Logo InterCure Ltd.
InterCure Ltd. is an Israel-based company engaged in the medical cannabis industry. Through its wholly owned subsidiary, Canndoc Ltd., the Company cultivates, produces, processes, markets, and distributes medical cannabis products. Its operations include the development and manufacture of pharmaceutical-grade medical cannabis products produced in accordance with Good Manufacturing Practice (GMP) standards. The Company offers a range of cannabis-based products for medical use and operates across various stages of the medical cannabis value chain, including cultivation, manufacturing, logistics, distribution, and retail activities. In addition, the Company is involved in the import, export, and commercialization of medical cannabis products and related healthcare solutions in Israel and selected international markets.
Employees
285
Date Price Change Volume
24/07/26 ILA 294.10 +1.94% 25,897
22/07/26 ILA 288.50 +2.30% 54,200
21/07/26 ILA 282.00 -2.46% 17,279
20/07/26 ILA 289.10 +1.47% 103,511
  1. Stock Market
  2. Stocks
  3. INCR Stock